Easy-to-Grasp Explanations: Immune Checkpoint Inhibitors, PD-1, PD-L1, CTLA-4

  Рет қаралды 913

StudyMed

StudyMed

Күн бұрын

Пікірлер: 5
@GiasAhmed-tq8cx
@GiasAhmed-tq8cx 5 ай бұрын
Very helpful! Thanks!
@StudyMedwithDr.chatMD.Phd3210
@StudyMedwithDr.chatMD.Phd3210 5 ай бұрын
Glad it was helpful!
@smmedchannel376
@smmedchannel376 8 ай бұрын
Nice explanation, thank you
@StudyMedwithDr.chatMD.Phd3210
@StudyMedwithDr.chatMD.Phd3210 8 ай бұрын
Thank you for your comment! 😊
@StudyMedwithDr.chatMD.Phd3210
@StudyMedwithDr.chatMD.Phd3210 8 ай бұрын
I would be happy if this video could be of any help to you 😊
Immune Checkpoint Inhibitors
8:17
Curie Oncology SG
Рет қаралды 12 М.
CTLA4 and attenuation of T cell response
5:58
Animated biology With arpan
Рет қаралды 39 М.
Why no RONALDO?! 🤔⚽️
00:28
Celine Dept
Рет қаралды 99 МЛН
What type of pedestrian are you?😄 #tiktok #elsarca
00:28
Elsa Arca
Рет қаралды 40 МЛН
Turn Off the Vacum And Sit Back and Laugh 🤣
00:34
SKITSFUL
Рет қаралды 9 МЛН
SIZE DOESN’T MATTER @benjaminjiujitsu
00:46
Natan por Aí
Рет қаралды 7 МЛН
Cancer Immune Checkpoint Inhibitors
5:33
Harvard Medical School Continuing Education
Рет қаралды 28 М.
Arlene Sharpe: Roles of the PD-1 pathway in controlling tolerance & tumor immunity
50:03
Introduction to Cancer Biology (Part 1): Abnormal Signal Transduction
7:47
Mechanisms in Medicine
Рет қаралды 720 М.
P450 Enzyme System (Inducers, Inhibitors, & Subtypes)
13:46
Dirty Medicine
Рет қаралды 370 М.
Immune Checkpoint Proteins
12:12
Creative BioMart
Рет қаралды 27 М.
Understanding Immunotherapy for NSCLC with PD-1 and PD-L1 Biomarkers
4:27
You and Lung Cancer
Рет қаралды 7 М.
How to manage toxicities from Immune Checkpoint Inhibitors?
7:25
European Society for Medical Oncology (ESMO)
Рет қаралды 3,6 М.
Immunotherapeutics with Dr. James Gulley
54:15
NIH Clinical Center
Рет қаралды 1,7 М.
Why no RONALDO?! 🤔⚽️
00:28
Celine Dept
Рет қаралды 99 МЛН